Quantcast

Latest Epidermal growth factor receptor Stories

2008-06-24 02:30:29

SOUTH SAN FRANCISCO, Calif., June 23, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it will present pre-clinical data on Menadione Topical Lotion and clinical data on Alocrest(tm) (vinorelbine liposomes injection, OPTISOME(tm)) at the European Society for Medical Oncology (ESMO) Conference taking place July 3-6, 2008 in Lugano, Switzerland. Menadione is a topical agent that Hana...

2008-03-05 09:01:06

Response Genetics, Inc. (NASDAQ: RGDX) announced today that its ResponseDX: Lung™ and ResponseDX: Colon™ tests are now available to select medical institutions and practice groups through its CLIA-registered laboratory. ResponseDX: Lung™ and ResponseDX: Colon™ are PCR-based tests that help guide therapeutic treatment decisions in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The tests are in their initial launch phase and are...

2008-01-16 03:00:13

By Yip, Stephen Iafrate, A John; Louis, David N Abstract Advances in understanding the molecular underpinnings of cancer and in molecular diagnostic technologies have changed the clinical practice of oncologic pathology. The development of targeted therapies against specific molecular alterations in cancer further portends changes in the role of the pathology laboratory to guide such custom therapies. To reconcile the flood of scientific discoveries in this area, the promises of highly...

2005-11-16 14:44:20

CAMBRIDGE, Mass., Nov. 16, 2005 -- When found at abnormally high concentrations, two proteins implicated in many human cancers have the potential to spur indiscriminate biochemical signaling inside cells, chemists at Harvard University have found. Their finding may expand scientists' current understanding of oncogenesis -- that cancer arises when an oncoprotein becomes overactive, ramping up the biochemical pathways that it normally activates -- suggesting that an important additional...

2005-10-07 13:50:37

Researchers from the University of California, San Francisco and Georgia Institute of Technology have found a new way to kill cancer cells. Building on their previous work that used gold nanoparticles to detect cancer, they now are heating the particles and using them as agents to destroy malignant cells. The researchers are a father and son, working together on opposite coasts. Their study findings are reported in the on-line edition of the journal Cancer Letters, found at Sciencedirect.com...

2005-08-09 16:04:13

LOS ANGELES (August 9, 2005; 5:00 p.m., EDT) "“ By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes. As the molecular engines that control all functions of the body, scientists wanted to find out how proteins work to promote health, or malfunction to cause disease. Subsequently, their discoveries have led to the development of a whole new arsenal of therapies designed to target...

2005-07-13 14:30:00

(Toronto "“ July 13, 2005) "“ An international clinical trial led by Canadian researchers has demonstrated that a drug called erlotinib increases survival in patients with advanced non-small cell lung cancer who typically have no other treatment options. The trial, funded by the Canadian Cancer Society and published in tomorrow's issue of The New England Journal of Medicine, involved 731 patients at centres in North and South America, Europe, Israel, New Zealand, Asia and South...

2005-06-14 23:08:48

Researchers have found two biomarkers that, in patients with a malignant type of brain tumor called glioblastoma multiforme, were associated with response to the cancer drug erlotinib (Tarceva). Patients with tumors that expressed high levels of epidermal growth factor receptor (EGFR) and low levels of phosphorylated PKB/Akt, an enzyme, responded better to erlotinib than patients with low levels of EGFR expression and high levels of phosphorylated PKB/Akt. The study findings appear in the...

2005-06-13 16:29:09

Scientists have uncovered new information about a specific mechanism involved in the biology of malignant human tumor cells. The findings, published in the June issue of Cancer Cell, significantly advance knowledge about epidermal growth factor receptor (EGFR). EGFR is a well-studied cell surface receptor that stimulates cell growth by transmitting growth factor signals acting outside the cell. EGFR is often present at abnormally elevated levels in human cancer cells. Increased EGFR activity...

2005-06-03 19:17:14

Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, say medical researchers from the University of California, San Francisco and Georgia Institute of Technology. The researchers are a father and son, working together on opposite coasts. Their study findings are reported in a recent edition (May 11) of the journal Nano Letters, published by the American Chemical Society. Principal author is Ivan El-Sayed, MD, assistant professor of...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related